Table of Content

1 INTRODUCTION (Page No. - 39)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
                    FIGURE 1 HEALTHCARE ANALYTICS MARKET SEGMENTATION
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY CONSIDERED 
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
2 RESEARCH METHODOLOGY (Page No. - 44)
    2.1 RESEARCH APPROACH 
    2.2 RESEARCH METHODOLOGY DESIGN 
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Insights from primary experts
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION 
          FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
          FIGURE 7 REVENUE ANALYSIS OF TOP THREE PUBLIC COMPANIES: HEALTHCARE ANALYTICS MARKET (2021)
          FIGURE 8 BOTTOM-UP APPROACH: END-USER ADOPTION/CONSUMPTION OF HEALTHCARE ANALYTICS (US)
          FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)
          FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
          FIGURE 11 TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 12 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ESTIMATION 
    2.6 STUDY ASSUMPTIONS 
    2.7 RESEARCH LIMITATIONS 
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
           2.7.2 SCOPE-RELATED LIMITATIONS
    2.8 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT: HEALTHCARE ANALYTICS MARKET
3 EXECUTIVE SUMMARY (Page No. - 59)
    FIGURE 13 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 15 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
    FIGURE 16 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2022 VS. 2027 (USD MILLION)
    FIGURE 17 HEALTHCARE ANALYTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 18 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE ANALYTICS MARKET
4 PREMIUM INSIGHTS (Page No. - 64)
    4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW 
          FIGURE 19 GOVERNMENT INITIATIVES TO INCREASE EHR ADOPTION AND CURB HEALTHCARE COSTS
    4.2 FINANCIAL ANALYTICS MARKET SHARE, BY TYPE AND REGION (2021) 
          FIGURE 20 NORTH AMERICA HELD LARGEST SHARE OF FINANCIAL ANALYTICS MARKET IN 2021
    4.3 HEALTHCARE ANALYTICS MARKET: GROWTH RATES 
          FIGURE 21 US TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
    4.4 REGIONAL MIX: HEALTHCARE ANALYTICS MARKET 
          FIGURE 22 NORTH AMERICA DOMINATED MARKET IN 2021
5 MARKET OVERVIEW (Page No. - 67)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 23 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Government initiatives to increase EHR adoption
                                FIGURE 24 EHR ADOPTION RATE AMONG HOSPITALS AND PHYSICIANS (2015–2021)
                    5.2.1.2 Growing venture capital investments in healthcare analytics start-ups
                    5.2.1.3 Growing pressure to curb healthcare spending and improve patient outcomes
                                FIGURE 25 HEALTHCARE SPENDING AS PERCENTAGE OF GDP, BY COUNTRY, 2019
                    5.2.1.4 Heterogeneity and complexity of big data in healthcare
                    5.2.1.5 Growing focus on real-world evidence
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of analytics solutions in healthcare organizations
                    5.2.2.2 Rising data breach concerns
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing focus on value-based medicines
                    5.2.3.2 Use of analytics in precision and personalized medicines
                    5.2.3.3 Cloud-based analytics
                    5.2.3.4 Increasing number of patient registries
                    5.2.3.5 Emergence of social media and its impact on healthcare industry
                    5.2.3.6 Augmented analytics to supplement human intelligence
                    5.2.3.7 Growing adoption of internet of healthcare things (IoHT)
           5.2.4 CHALLENGES
                    5.2.4.1 Concerns regarding inaccurate and inconsistent data
                    5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries
                    5.2.4.3 Data integration for coordinated care
                    5.2.4.4 Operational gaps between payers and providers
                    5.2.4.5 Dearth of skilled personnel
    5.3 ECOSYSTEM ANALYSIS 
          FIGURE 26 ECOSYSTEM ANALYSIS: HEALTHCARE ANALYTICS MARKET
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 27 VALUE CHAIN ANALYSIS: HEALTHCARE ANALYTICS MARKET
    5.5 CASE STUDY ANALYSIS 
           5.5.1 CASE STUDY 1
           5.5.2 CASE STUDY 2
           5.5.3 CASE STUDY 3
           5.5.4 CASE STUDY 4
    5.6 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 2 PORTER’S FIVE FORCES ANALYSIS: HEALTHCARE ANALYTICS MARKET
           5.6.1 THREAT FROM NEW ENTRANTS
           5.6.2 THREAT FROM SUBSTITUTES
           5.6.3 BARGAINING POWER OF SUPPLIERS
           5.6.4 BARGAINING POWER OF BUYERS
           5.6.5 INTENSITY OF COMPETITIVE RIVALRY
    5.7 REGULATORY ANALYSIS 
           5.7.1 NORTH AMERICA
           5.7.2 EUROPE
           5.7.3 ASIA PACIFIC
           5.7.4 MIDDLE EAST & AFRICA
           5.7.5 LATIN AMERICA
    5.8 TECHNOLOGY ANALYSIS 
           5.8.1 MACHINE LEARNING
           5.8.2 ARTIFICIAL INTELLIGENCE
           5.8.3 INTERNET OF THINGS
           5.8.4 BLOCKCHAIN
           5.8.5 BIG DATA
    5.9 INDUSTRY TRENDS 
           5.9.1 INCREASING PARTNERSHIPS AND COLLABORATIONS FOR INNOVATION
           5.9.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
           5.9.3 CLOUD-BASED IT SOLUTIONS
    5.10 PRICING ANALYSIS 
           TABLE 3 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY APPLICATION
    5.11 AVERAGE SELLING PRICE TREND ANALYSIS 
    5.12 PATENT ANALYSIS 
           FIGURE 28 PATENT ANALYSIS: HEALTHCARE ANALYTICS MARKET (JANUARY 2017–SEPTEMBER 2022)
           5.12.1 PATENTS: HEALTHCARE ANALYTICS MARKET
    5.13 KEY CONFERENCES AND EVENTS IN 2022–2023 
           TABLE 4 HEALTHCARE ANALYTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
                     TABLE 5 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
           5.14.2 BUYING CRITERIA
                     FIGURE 30 KEY BUYING CRITERIA FOR END USERS
                     TABLE 6 KEY BUYING CRITERIA FOR END USERS
6 HEALTHCARE ANALYTICS MARKET, BY TYPE (Page No. - 96)
    6.1 INTRODUCTION 
          TABLE 7 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
    6.2 DESCRIPTIVE ANALYTICS 
           6.2.1 DESCRIPTIVE ANALYTICS TO CONVERT PAST DATA INTO USEFUL INFORMATION
                    TABLE 8 HEALTHCARE ANALYTICS MARKET FOR DESCRIPTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
    6.3 PREDICTIVE ANALYTICS 
           6.3.1 GROWING USE OF PREDICTIVE ANALYTICS TO IDENTIFY HIGH-RISK PATIENTS TO DRIVE GROWTH
                    TABLE 9 HEALTHCARE ANALYTICS MARKET FOR PREDICTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
    6.4 PRESCRIPTIVE ANALYTICS 
           6.4.1 PRESCRIPTIVE ANALYTICS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
                    TABLE 10 HEALTHCARE ANALYTICS MARKET FOR PRESCRIPTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
    6.5 COGNITIVE ANALYTICS 
           6.5.1 INTRODUCTION OF AI-DRIVEN ANALYTICS SOLUTIONS TO BOOST MARKET
                    TABLE 11 HEALTHCARE ANALYTICS MARKET FOR COGNITIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
7 HEALTHCARE ANALYTICS MARKET, BY COMPONENT (Page No. - 103)
    7.1 INTRODUCTION 
          TABLE 12 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
    7.2 SERVICES 
          TABLE 13 HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 14 HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY REGION, 2020–2027 (USD MILLION)
           7.2.1 SUPPORT SERVICES
                    7.2.1.1 Support services to include implementation, ongoing IT support, system integration, training, and maintenance services
                                TABLE 15 HEALTHCARE ANALYTICS SUPPORT SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           7.2.2 BUSINESS ANALYTICS SERVICES
                    7.2.2.1 Business analytics services to help healthcare organizations optimize use of analytics and drive performance improvement
                                TABLE 16 HEALTHCARE BUSINESS ANALYTICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.3 SOFTWARE 
           7.3.1 HEALTHCARE ANALYTICS SOFTWARE TO WORK AS INTERFACE BETWEEN DATABASE AND END USERS
                    TABLE 17 HEALTHCARE ANALYTICS MARKET FOR SOFTWARE, BY REGION, 2020–2027 (USD MILLION)
    7.4 HARDWARE 
           7.4.1 INCREASING ADOPTION OF CLOUD SERVERS TO HINDER GROWTH
                    TABLE 18 HEALTHCARE ANALYTICS MARKET FOR HARDWARE, BY REGION, 2020–2027 (USD MILLION)
8 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL (Page No. - 110)
    8.1 INTRODUCTION 
          TABLE 19 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
    8.2 ON-PREMISE DEPLOYMENT 
           8.2.1 MULTIVENDOR ARCHITECTURE TO LOWER RISK OF DATA BREACHES AND EXTERNAL ATTACKS
                    TABLE 20 ON-PREMISE SOLUTIONS AVAILABLE
                    TABLE 21 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE DEPLOYMENT MODEL, BY REGION, 2020–2027 (USD MILLION)
    8.3 ON-DEMAND DEPLOYMENT 
           8.3.1 INCREASING VOLUME OF DATA GENERATED TO DRIVE ADOPTION
                    TABLE 22 ON-DEMAND SOLUTIONS AVAILABLE
                    TABLE 23 HEALTHCARE ANALYTICS MARKET FOR ON-DEMAND DEPLOYMENT MODEL, BY REGION, 2020–2027 (USD MILLION)
9 HEALTHCARE ANALYTICS MARKET, BY APPLICATION (Page No. - 114)
    9.1 INTRODUCTION 
          TABLE 24 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    9.2 FINANCIAL ANALYTICS 
          TABLE 25 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS
          TABLE 26 HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 27 HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
           9.2.1 CLAIMS PROCESSING
                    9.2.1.1 Improvement in claims response time and avoidance of fraudulent claims to support market
                                TABLE 28 COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS
                                TABLE 29 HEALTHCARE ANALYTICS MARKET FOR CLAIMS PROCESSING, BY REGION, 2020–2027 (USD MILLION)
           9.2.2 REVENUE CYCLE MANAGEMENT
                    9.2.2.1 Healthcare organizations to adopt predictive analytics solutions for proactive decision-making
                                TABLE 30 COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS
                                TABLE 31 HEALTHCARE ANALYTICS MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2020–2027 (USD MILLION)
           9.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE (FWA)
                    9.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to boost market
                                TABLE 32 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS
                                TABLE 33 HEALTHCARE ANALYTICS MARKET FOR PAYMENT INTEGRITY & FWA, BY REGION, 2020–2027 (USD MILLION)
           9.2.4 RISK ADJUSTMENT & ASSESSMENT
                    9.2.4.1 Optimization of cash flows and improved financial performance to aid market
                                TABLE 34 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS
                                TABLE 35 HEALTHCARE ANALYTICS MARKET FOR RISK ADJUSTMENT & ASSESSMENT, BY REGION, 2020–2027 (USD MILLION)
    9.3 CLINICAL ANALYTICS 
          TABLE 36 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS
          TABLE 37 HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 38 HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
           9.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
                    9.3.1.1 Benchmarking to identify and manage issues that negatively impact healthcare systems
                                TABLE 39 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL BENCHMARKING SOLUTIONS
                                TABLE 40 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.3.2 CLINICAL DECISION SUPPORT
                    9.3.2.1 Reduction of medical errors and performance of appropriate tests to augment market
                                TABLE 41 COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT
                                TABLE 42 CLINICAL DECISION SUPPORT MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.3.3 REPORTING & COMPLIANCE
                    9.3.3.1 Stringent regulatory requirements to accelerate market
                                TABLE 43 COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE
                                TABLE 44 REPORTING & COMPLIANCE MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS
                    9.3.4.1 Growing adoption of EHRs to provide growth
                                TABLE 45 COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS
                                TABLE 46 COMPARATIVE ANALYTICS/EFFECTIVENESS MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.3.5 PRECISION HEALTH
                    9.3.5.1 Strong government support for personalized medicine to drive market
                                TABLE 47 COMMERCIALLY AVAILABLE PRECISION HEALTH SOLUTIONS
                                TABLE 48 PRECISION HEALTH MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.3.6 MEDICAL IMAGING ANALYTICS
                    9.3.6.1 Imaging analytics aided by artificial intelligence and machine learning to fuel market
                                TABLE 49 COMMERCIALLY AVAILABLE SOLUTIONS FOR MEDICAL IMAGING ANALYTICS
                                TABLE 50 MEDICAL IMAGING ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS 
          TABLE 51 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS
          TABLE 52 HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 53 HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
           9.4.1 SUPPLY CHAIN ANALYTICS
                    9.4.1.1 Informed decisions about costs, medication, and equipment to propel market
                                TABLE 54 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS
                                TABLE 55 SUPPLY CHAIN ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.4.2 WORKFORCE ANALYTICS
                    9.4.2.1 Need for real-time resource demand and supply data to drive adoption of workforce analytics
                                TABLE 56 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS
                                TABLE 57 WORKFORCE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.4.3 STRATEGIC ANALYTICS
                    9.4.3.1 Strategic analytics to use advanced analytics tools and leverage operational data
                                TABLE 58 STRATEGIC ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.5 POPULATION HEALTH ANALYTICS 
           9.5.1 IMPROVING POPULATION HEALTH OUTCOMES AND LOWERING COSTS TO DRIVE GROWTH
                    TABLE 59 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS
                    TABLE 60 HEALTHCARE ANALYTICS MARKET FOR POPULATION HEALTH ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
10 HEALTHCARE ANALYTICS MARKET, BY END USER (Page No. - 136)
     10.1 INTRODUCTION 
                       TABLE 61 HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.2 PAYERS 
             TABLE 62 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 63 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION, 2020–2027 (USD MILLION)
             10.2.1 PRIVATE INSURANCE COMPANIES
                        10.2.1.1 Private insurance companies to account for largest market share
                                      TABLE 64 PRIVATE INSURANCE COMPANIES MARKET, BY REGION, 2020–2027 (USD MILLION)
             10.2.2 GOVERNMENT AGENCIES
                        10.2.2.1 Increasing use of analytics solutions to boost market
                                      TABLE 65 GOVERNMENT AGENCIES MARKET, BY REGION, 2020–2027 (USD MILLION)
             10.2.3 EMPLOYERS & PRIVATE EXCHANGES
                        10.2.3.1 Employers & private exchanges to use data analytics for rapid data integration, health plan analysis, and risk modeling
                                      TABLE 66 EMPLOYERS & PRIVATE EXCHANGES MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.3 PROVIDERS 
             TABLE 67 HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS
                        10.3.1.1 Adoption of healthcare analytics solutions to drive growth
                                      TABLE 68 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS MARKET, BY REGION, 2020–2027 (USD MILLION)
             10.3.2 POST-ACUTE CARE ORGANIZATIONS
                        10.3.2.1 Post-acute care organizations to review and study patient data using healthcare analytics
                                      TABLE 69 POST-ACUTE CARE ORGANIZATIONS MARKET, BY REGION,2020–2027 (USD MILLION)
             10.3.3 AMBULATORY SETTINGS
                        10.3.3.1 Management of population health and need to control healthcare costs to support market
                                      TABLE 70 AMBULATORY SETTINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.4 ACOS, HIES, MCOS, AND TPAS 
             TABLE 71 HEALTHCARE ANALYTICS MARKET FOR ACOS, HIES, MCOS, AND TPAS, BY REGION, 2020–2027 (USD MILLION)
11 HEALTHCARE ANALYTICS MARKET, BY REGION (Page No. - 149)
     11.1 INTRODUCTION 
             TABLE 72 HEALTHCARE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 31 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
             TABLE 73 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 74 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 75 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 76 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
             TABLE 77 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 78 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 79 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 80 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 81 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
             TABLE 82 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             TABLE 83 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 84 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.2.1 US
                        11.2.1.1 High adoption of EHRs to drive market
                                      TABLE 85 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 86 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 87 US: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 88 US: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 89 US: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 90 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 91 US: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 92 US: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 93 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 94 US: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 95 US: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 Need for managing patient volumes, clinical data, and healthcare costs to fuel market
                                      TABLE 96 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 97 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 98 CANADA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 99 CANADA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 100 CANADA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 101 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 102 CANADA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 103 CANADA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 104 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 105 CANADA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 106 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
     11.3 EUROPE 
             FIGURE 32 EUROPE: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
             TABLE 107 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 108 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027(USD MILLION)
             TABLE 109 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 110 EUROPE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 111 EUROPE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 112 EUROPE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 113 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 114 EUROPE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 115 EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
             TABLE 116 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             TABLE 117 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 118 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 Government initiatives to increase use of analytics in healthcare
                                      TABLE 119 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 120 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 121 GERMANY: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
                                      TABLE 122 GERMANY: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 123 GERMANY: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 124 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 125 GERMANY: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 126 GERMANY: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 127 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 128 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 129 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 Availability of venture capital investments to drive market
                                      TABLE 130 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 131 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 132 UK: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 133 UK: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 134 UK: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 135 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 136 UK: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 137 UK: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 138 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 139 UK: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 140 UK: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Strong financial support for digital health to augment market
                                      TABLE 141 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 142 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 143 FRANCE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 144 FRANCE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 145 FRANCE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 146 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 147 FRANCE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 148 FRANCE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 149 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 150 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 151 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.3.4 REST OF EUROPE
                        TABLE 152 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 153 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 154 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
                        TABLE 155 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 156 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 157 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 158 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 159 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                        TABLE 160 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                        TABLE 161 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 162 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
     11.4 ASIA 
             FIGURE 33 ASIA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
             TABLE 163 ASIA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 164 ASIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 165 ASIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 166 ASIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 167 ASIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
             TABLE 168 ASIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 169 ASIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 170 ASIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 171 ASIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
             TABLE 172 ASIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             TABLE 173 ASIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 174 ASIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.4.1 JAPAN
                        11.4.1.1 Rise in geriatric population to demand effective patient management solutions
                                      TABLE 175 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 176 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 177 JAPAN: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 178 JAPAN: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 179 JAPAN: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 180 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 181 JAPAN: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 182 JAPAN: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 183 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 184 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 185 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.4.2 CHINA
                        11.4.2.1 Favorable reforms and growing number of EHRs to aid market
                                      TABLE 186 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 187 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 188 CHINA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 189 CHINA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 190 CHINA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 191 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 192 CHINA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 193 CHINA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 194 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 195 CHINA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 196 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.4.3 INDIA
                        11.4.3.1 Low healthcare expenditure by government and slow adoption of healthcare analytics solutions to restrain market
                                      TABLE 197 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 198 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 199 INDIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 200 INDIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 201 INDIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 202 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 203 INDIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 204 INDIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 205 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 206 INDIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 207 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.4.4 REST OF ASIA
                        TABLE 208 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 209 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 210 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 211 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 212 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 213 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 214 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 215 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                        TABLE 216 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                        TABLE 217 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 218 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
     11.5 PACIFIC COUNTRIES 
             11.5.1 NEED TO REDUCE HEALTHCARE COSTS IN AUSTRALIA AND NEW ZEALAND TO DRIVE MARKET
                        TABLE 219 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 220 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 221 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 222 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
                        TABLE 223 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 224 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 225 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 226 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                        TABLE 227 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                        TABLE 228 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 229 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
     11.6 LATIN AMERICA 
             11.6.1 GROWING E-HEALTH INITIATIVES TO PROPEL MARKET
                        TABLE 230 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 231 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 232 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 233 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 234 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 235 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 236 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 237 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                        TABLE 238 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                        TABLE 239 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 240 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
     11.7 MIDDLE EAST & AFRICA 
             11.7.1 HIGH HEALTHCARE EXPENDITURE AND INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET
                        TABLE 241 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 242 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 243 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 244 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
                        TABLE 245 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 246 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 247 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 248 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                        TABLE 249 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
                        TABLE 250 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 251 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 236)
     12.1 INTRODUCTION 
     12.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
     12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICS MARKET
     12.4 MARKET RANKING ANALYSIS, 2021 
             FIGURE 35 HEALTHCARE ANALYTICS MARKET RANKING ANALYSIS, 2021
     12.5 COMPANY LEADERSHIP MAPPING 
             12.5.1 STARS
             12.5.2 PERVASIVE PLAYERS
             12.5.3 EMERGING LEADERS
             12.5.4 PARTICIPANTS
                        FIGURE 36 HEALTHCARE ANALYTICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
     12.6 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES (2021) 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 STARTING BLOCKS
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 DYNAMIC COMPANIES
                        FIGURE 37 HEALTHCARE ANALYTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
     12.7 COMPETITIVE BENCHMARKING 
             FIGURE 38 OVERALL FOOTPRINT OF COMPANIES (17 COMPANIES)
             TABLE 252 APPLICATION FOOTPRINT OF COMPANIES
             TABLE 253 END-USER FOOTPRINT OF COMPANIES
             TABLE 254 REGIONAL FOOTPRINT OF COMPANIES
     12.8 COMPETITIVE SCENARIO 
             12.8.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 255 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–OCTOBER 2022
             12.8.2 DEALS
                        TABLE 256 DEALS, JANUARY 2019–OCTOBER 2022
             12.8.3 OTHER DEVELOPMENTS
                        TABLE 257 OTHER DEVELOPMENTS, JANUARY 2019–OCTOBER 2022
13 COMPANY PROFILES (Page No. - 256)
(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)*
     13.1 KEY PLAYERS 
             13.1.1 IBM
                        TABLE 258 IBM: COMPANY OVERVIEW
                        FIGURE 39 IBM: COMPANY SNAPSHOT (2021)
             13.1.2 SAS INSTITUTE INC.
                        TABLE 259 SAS INSTITUTE INC.: COMPANY OVERVIEW
                        FIGURE 40 SAS INSTITUTE INC.: COMPANY SNAPSHOT (2021)
             13.1.3 OPTUM, INC.
                        TABLE 260 OPTUM, INC.: COMPANY OVERVIEW
                        FIGURE 41 OPTUM, INC.: COMPANY SNAPSHOT (2021)
             13.1.4 CERNER CORPORATION
                        TABLE 261 CERNER CORPORATION: COMPANY OVERVIEW
                        FIGURE 42 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
             13.1.5 ALLSCRIPTS HEALTHCARE, LLC
                        TABLE 262 ALLSCRIPTS HEALTHCARE, LLC: COMPANY OVERVIEW
                        FIGURE 43 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
             13.1.6 COTIVITI, INC.
                        TABLE 263 COTIVITI, INC.: COMPANY OVERVIEW
             13.1.7 CITIUSTECH INC.
                        TABLE 264 CITIUSTECH INC.: COMPANY OVERVIEW
             13.1.8 HEALTH CATALYST
                        TABLE 265 HEALTH CATALYST: COMPANY OVERVIEW
                        FIGURE 44 HEALTH CATALYST: COMPANY SNAPSHOT (2021)
             13.1.9 CVS HEALTH
                        TABLE 266 CVS HEALTH: COMPANY OVERVIEW
                        FIGURE 45 CVS HEALTH: COMPANY SNAPSHOT (2021)
             13.1.10 INOVALON
                        TABLE 267 INOVALON: COMPANY OVERVIEW
                        FIGURE 46 INOVALON: COMPANY SNAPSHOT (2021)
             13.1.11 MCKESSON CORPORATION
                        TABLE 268 MCKESSON CORPORATION: COMPANY OVERVIEW
                        FIGURE 47 MCKESSON CORPORATION.: COMPANY SNAPSHOT (2021)
             13.1.12 MEDEANALYTICS, INC.
                        TABLE 269 MEDEANALYTICS, INC.: COMPANY OVERVIEW
             13.1.13 ORACLE
                        TABLE 270 ORACLE: COMPANY OVERVIEW
                        FIGURE 48 ORACLE: COMPANY SNAPSHOT (2022)
             13.1.14 EXLSERVICE HOLDINGS, INC.
                        TABLE 271 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW
                        FIGURE 49 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2021)
             13.1.15 GAINWELL.
                        TABLE 272 GAINWELL: COMPANY OVERVIEW
             13.1.16 WIPRO
                        TABLE 273 WIPRO: COMPANY OVERVIEW
                        FIGURE 50 WIPRO: COMPANY SNAPSHOT (2022)
     13.2 OTHER PLAYERS 
             13.2.1 FLATIRON
                        TABLE 274 FLATIRON: COMPANY OVERVIEW
             13.2.2 APIXIO
                        TABLE 275 APIXIO: COMPANY OVERVIEW
             13.2.3 ENLITIC, INC.
                        TABLE 276 ENLITIC, INC.: COMPANY OVERVIEW
             13.2.4 KOMODO HEALTH, INC.
                        TABLE 277 KOMODO HEALTH, INC.: COMPANY OVERVIEW
             13.2.5 HEALTHEC, LLC
                        TABLE 278 HEALTHEC, LLC: COMPANY OVERVIEW
             13.2.6 SEMA4 OPCO, INC.
             13.2.7 EVIDATION HEALTH, INC.
             13.2.8 INSILICO MEDICINE
             13.2.9 EXSCIENTIA
             13.2.10 AETION, INC.
             13.2.11 PREMIER
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 326)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS